PubMed
Evaluation and treatment of adult growth hormone deficiency: an Endocrine Society clinical practice guideline
Molitch et al., 2011
Hormonal & EndocrineFDA Approved (indication-specific)A
HGH (Somatropin)
Human Growth Hormone / rhGH
Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.
Observational report only — live community data. Not medical advice. Does not recommend doses, protocols, or treatments.
- Studies cited
- 5
- Research grade
- A
- Experience
- 56
- Activity
- 69
Overall check-ins
Trackers & reports
Overview
About HGH (Somatropin)
Human Growth Hormone (somatropin, rhGH) is a recombinant form of endogenous growth hormone used clinically for growth hormone deficiency and selected catabolic conditions. It remains one of the most studied anabolic endocrine therapies, with extensive evidence in pediatric and adult GHD populations and ongoing registry data for long-term outcomes. Off-label use for body composition and anti-aging remains medically controversial and should be physician-supervised.
- Category
- Hormonal & Endocrine
- Regulatory status
- FDA Approved (indication-specific)
- Also known as
- Human Growth Hormone / rhGH
- Self-reports
- 28
Community
What 28 users report
28 community reports
Overall experience
From check-in ratings — separate from side effects logged below. Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Favorable 2% · Mixed 98% · Unfavorable overall 0%
Most reported benefits
Benefits users selected when logging a favorable or mixed check-in.
Appetite
167
Recovery
167
Most logged side effects
Side effects are logged separately from overall experience. A favorable check-in can still include nausea, fatigue, or injection-site reactions.
Water retention
164
Self-reported dose per injection
Median bucket: 0–0.025 mg · Most common: 0–0.025 mg
Reports span 0 to ≥ 2 mg (open-ended top bucket)
0–0.025 mg
144
0.6–1 mg
6
2+ mg
17
Anonymized self-reports from PeptIQ users — not prescribing guidance. Buckets group similar logged amounts; open-ended top buckets mean “at least” that dose.
Commonly stacked with
How repeat users are trending
Among repeat reporters, 88% said they felt similar to their last entry, 12% more positive, and 0% more negative.
Overall, repeat reporters leaned more positive than their previous entry.
Median gap between entries: 133 days · Based on 26 repeat reporters
Research
Cited research (3)
Source
PubMed
Efficacy, safety, quality of life, adherence and cost-effectiveness of long-acting growth hormone replacement therapy compared to daily growth hormone in children with growth hormone deficiency: A systematic review and meta-analysis
Mameli et al., 2023
PubMed
Acromegaly
Colao et al., 2019
Tools
Explore more
Explore
More ways to learn about HGH (Somatropin) from observational PeptIQ data.
Compare with
Related peptides
Help
Frequently asked
What do PeptIQ users report about HGH (Somatropin)?
This page summarizes 28 anonymized self-reports from PeptIQ users who track HGH (Somatropin), including commonly reported effects and co-tracked peptides. These are observational patterns, not clinical outcomes.
How do side effects relate to overall experience for HGH (Somatropin)?
PeptIQ separates overall check-in ratings (favorable, mixed, or unfavorable) from logged side effects like nausea or fatigue. Users often report benefits and side effects in the same check-in — a high experience score does not mean zero side effects were noted.
What research is cited for HGH (Somatropin)?
3 sources are linked on this page, including PubMed articles, clinical trial registries, and FDA labels where applicable. Citations describe published research — not recommendations.
Is HGH (Somatropin) safe to use?
This wiki does not assess safety or recommend use. HGH (Somatropin) is listed as FDA Approved (indication-specific). Consult a licensed clinician for personal medical decisions.
What are the purported benefits and uses of HGH (Somatropin)?
Research, primarily in animal models, suggests HGH (Somatropin) may have a wide range of therapeutic potentials due to its ability to promote angiogenesis (formation of new blood vessels), stimulate collagen synthesis, and modulate inflammatory responses.
SourceWhat is the legal status of HGH (Somatropin)?
HGH (Somatropin) is not approved by the FDA for any human use. There is no legal basis for selling it as a drug, food, or dietary supplement in the United States. The FDA has classified HGH (Somatropin) as a Category 2 bulk drug substance, which explicitly prohibits licensed compounding pharmacies from using it in compounded medications.
SourceWhat are the known or theoretical side effects and risks of HGH (Somatropin)?
The safety and effectiveness of HGH (Somatropin) have not been thoroughly evaluated in humans through rigorous clinical trials. This lack of human data means that safe dosages, short-term side effects, and long-term health consequences are largely unknown.
SourceWhat is the current state of research on HGH (Somatropin)?
While there are over 200 published studies on HGH (Somatropin), the vast majority are animal or in vitro (cell) studies. These preclinical studies consistently show positive results across various tissue types. However, there is a significant lack of comprehensive human clinical trial data.
Source